Does antidepressant medication in patients with hepatitis C undergoing interferon alpha treatment reduce therapeutic efficacy?
Robaeys
G
G
Wichers
M C
MC
De Bie
J
J
Koek
G H
GH
Buntinx
F
F
Van Os
J
J
D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000009:adverse effects; D003863:Depression / Q000188:drug therapy*; D004347:Drug Interactions; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D018687:Antidepressive Agents, Second-Generation; D000998:Antiviral Agents; D016898:Interferon-alpha; D017367:Selective Serotonin Reuptake Inhibitors